Is semaglutide covered by Medicare in Nevada?
Traditional Medicare Part D has not covered GLP-1 medications prescribed only for weight loss, though that is beginning to change in 2026. In the meantime, Vitality Weight Loss runs a GLP-1 Bridge that helps eligible Nevada Medicare members get brand-name Wegovy or Zepbound for about $50 per month. Eligibility is confirmed by the clinic.
What Medicare has covered, and what is changing
For years, Medicare Part D was prohibited from covering drugs used for weight loss, which kept GLP-1 medications out of reach for many older adults unless they were prescribed for type 2 diabetes. In 2026 that landscape is shifting as coverage rules evolve. Because the rules differ by plan and are still moving, the practical answer for most Nevada Medicare members today is to confirm coverage individually rather than assume.
How the Vitality GLP-1 Bridge works
Vitality built the GLP-1 Bridge specifically for Medicare-eligible patients. Rather than paying $1,000 or more out of pocket, eligible members can access brand-name Wegovy (semaglutide) or Zepbound (tirzepatide) for roughly $50 per month. The clinic confirms your eligibility based on your Medicare plan and medical history, and Dr. DeBry reviews every case before any prescription.
How to find out if you qualify
- Complete Vitality's short medical intake (about 3 minutes).
- The clinic reviews your Medicare plan and history, usually within one business day.
- If eligible, you are guided through the Bridge. If not, the clinic discusses other options.
There is no charge to check, and no obligation.
Check your Medicare GLP-1 eligibility.
3-minute intake, reviewed by Dr. DeBry. No charge to find out what you qualify for.
Check eligibility →This page is for general education and is not a substitute for individual medical or insurance advice. Coverage depends on your specific Medicare plan.